A study from the University of Montreal adds to findings indicating the approach can help reduce sample complexity and interferences in quantitative work.
The tool is the latest such package to be released as the field continues to move towards open searching, which could significantly expand breadth of analysis.
The work suggests DIA can be a rapid way to confirm the outcome of CRISPR experiments while looking at the downstream effects of the targeted alterations.
The company is planning a 2020 commercial launch of PNNL's SLIM IMS tech, which could significantly improve the sensitivity and throughput of mass spec assays.
Developed in collaboration with Waters and Labcyte, the platform enables applications including high-throughput drug screening and metabolomic profiling.
University of Kansas researchers developed the technology, which could enable faster, more sensitive analysis of exosomes than existing microfluid platforms.
The study made use of a high-resolution mass spec approach developed by University of Minnesota scientists that allows for untargeted discovery of DNA adducts.
The approach allows researchers to profile the protein complexes present in a sample in much the same way they have the individual peptides and proteins.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.
